Skip to content

NATHYPHARM

Active Private limited companyfounded 2011active for 15 yearsRue du Bois de Siroux 36, 5300 AndenneKBO/BCE: BE 0837.507.106

Lifetime

13 annual accounts with figures on one time axis
peak of €98,452 in 2022
-€4,35518 months
lowest -€47,903 in 2024
-€47,90318 months
peak of €113,277 in 2023
€65,374▼ 42.3%
€275,260▲ 1.7%
Board1 name since 2011
- 
Documentsfilings and deeds
01-10-202562 days late
2024micro format
Financial year from 01-07-2023 to 31-12-2024, 18 monthsLoss of €47,903Equity from €113,277 to €65,374

Key points

from the 2024 annual accounts

Result

-€47,903 -€47,903
€15,8002023-€47,9002024

From profit to loss in 2024, after a profit of €15,804 in 2023.

Debts

€275,260 81% of the balance sheet
Financial debts 67%Suppliers 0%Taxes and wages 5%Other 29%

Of this, €91,277 falls due within a year.

Position in the sector

-€47,903

Lower net result than 95% of companies in retail trade. Sector median €4,554 · 25,606 companies.

2024 accounts filed 62 days after the deadlineTurnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,294 companies had the same profile as NATHYPHARM has now. Each dot stands for 4 companies, two years later.

89.6%
were still trading
5.9%
stopped another way
4.1%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a loss of 10% of the balance sheet or more

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,294 companies, not a prediction for NATHYPHARM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Manager, last mentioned in 2011
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0837507106
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments “L'achat,la vente,la préparation,la distribution sous toutes ses formes,en gros ou au détail,de tous produits…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Gazette deed
Incorporation Founded by · appointed as manager · Founder: · published on 06-07-2011 · Gazette deed
First establishment Rue du Bois de Siroux 36, Andenne
All 22 events

Comparable companies

same main activity, similar in size and age
Company
NATHYPHARM Andenne €340,634 -€4,355 19.2% -
THEUNISSEN-DE NEVE Aalst €291,003 -€539 13.6% -
Apotheek Ruben Jolie Erpe-Mere €363,985 -€8,360 2.7% -
PHARMACIE DARGENT Anderlecht €278,471 -€259 65.4% -
PHARMABAK Molenbeek-Saint-Jean €357,515 -€10,053 14.3% -
APOTHEEK DE LIEVE Lievegem €418,337 -€1,232 36.8% -
APOTHECA Saint-Josse-ten-Noode €286,294 -€547 63.0% -

These companies have the same main activity as NATHYPHARM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €278,000 and €418,000, founded between 2008 and 2015.

Official details

Source: KBO
Status
Active since 04-07-2011Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.200.552.7875300 Andenne, since 04-07-2011
Financial year end
31 December
Peppol
Reachable since 10-01-2026
Company details

Annual accounts 2024

€340,634
Filing
Filed on 01-10-2025
Financials

Insights on NATHYPHARM

NATHYPHARM files the micro format. That format states no turnover. The gross margin fell from €1,676 in 2012 to -€4,355 in 2024.

The balance sheet grew most from 2021 to 2023 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NATHYPHARM

What is the company number of NATHYPHARM?
The company number of NATHYPHARM is 0837.507.106. The VAT number is the same number with BE in front: BE 0837.507.106.
Where is NATHYPHARM based?
The registered office is at Rue du Bois de Siroux 36, 5300 Andenne.Company details
What does NATHYPHARM do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of NATHYPHARM?
NATHYPHARM is a private limited company (BV).
When was NATHYPHARM founded?
NATHYPHARM was founded on 04-07-2011.
Is NATHYPHARM still active?
Yes, NATHYPHARM is an active enterprise in the KBO register.
What is the turnover of NATHYPHARM?
The annual accounts for financial year 2024 state no turnover. The micro format does not require it. In financial year 2023 turnover was €172,669.Financials
Is NATHYPHARM profitable?
In financial year 2024, NATHYPHARM made a loss of €47,903.
Where can I find the annual accounts of NATHYPHARM?
NATHYPHARM filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.